News
  Date Title View
Sep 14, 2016
RoclatanTM Successfully Achieves Primary Efficacy Endpoint in Mercury 1 Study Conference Call and Webcast Today, September 14, at 5:00 p.m. ET IRVINE, Calif.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused...
Sep 6, 2016
IRVINE, Calif.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the submission of its N...
Page: FirstPrevious ...
5
= add release to Briefcase